Skip to main content

01.02.2014 | Epidemiology

Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The objective of this nationwide prospective cohort study is to find out the risk of breast cancer (BC) in relatives of patients with multiple BCs by laterality and age at diagnosis of first BC. Having family history of single (HR 1.8; 95 % CI 1.8–1.9) or multiple (HR 2.7; 95 % CI 2.6–2.9) BC was associated with higher risk of BC. Those with an FDR with contralateral BC at any age had the highest risk of familial cancer except at age <40 in which those whose young FDR was affected by multiple ipsilateral BC had the highest risk (HR 9.7; 95 % CI 6.0–15.6). The familial risk of BC in these families decreased as the subject’s and FDRs’ age at diagnosis of first BC increased. The HR was still significantly increased (2.2) for old individuals (>60) having a FDR with contralateral BC at an advanced age (≥80). Despite the common belief that later onset breast cancer is more associated with sporadic breast cancer, our data suggest that breast cancer at any age in the family is associated with some increase in the familial risk, though that risk decreases as the age of onset increases. Contralateral and multiple ipsilateral breast cancers might be associated with distinct shared familial risk factors. Our results have implication for genetic counseling and urge gene identification studies.
Literatur
1.
Zurück zum Zitat Evans DG, Lalloo F (2002) Risk assessment and management of high risk familial breast cancer. J Med Genet 39(12):865–871PubMedCrossRef Evans DG, Lalloo F (2002) Risk assessment and management of high risk familial breast cancer. J Med Genet 39(12):865–871PubMedCrossRef
2.
Zurück zum Zitat Kharazmi E, Fallah M, Sundquist K, Hemminki K (2012) Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ 345:e8076PubMedCentralPubMedCrossRef Kharazmi E, Fallah M, Sundquist K, Hemminki K (2012) Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ 345:e8076PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98(1):61–68PubMedCrossRef Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98(1):61–68PubMedCrossRef
4.
Zurück zum Zitat Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81–91PubMedCrossRef Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81–91PubMedCrossRef
5.
Zurück zum Zitat Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P (2001) The nation-wide Swedish Family Cancer Database: updated structure and familial rates. Acta Oncol 40(6):772–777PubMedCrossRef Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P (2001) The nation-wide Swedish Family Cancer Database: updated structure and familial rates. Acta Oncol 40(6):772–777PubMedCrossRef
6.
Zurück zum Zitat The National Board of Health and Welfare CfE (2007) Cancer incidence in Sweden 2006 The National Board of Health and Welfare CfE (2007) Cancer incidence in Sweden 2006
7.
Zurück zum Zitat Horn-Ross PL (1993) Multiple primary cancers involving the breast. Epidemiol Rev 15(1):169–176PubMed Horn-Ross PL (1993) Multiple primary cancers involving the breast. Epidemiol Rev 15(1):169–176PubMed
8.
Zurück zum Zitat Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998–1002PubMedCrossRef Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998–1002PubMedCrossRef
9.
Zurück zum Zitat Dong C, Hemminki K (2001) Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 92(6):883–887PubMedCrossRef Dong C, Hemminki K (2001) Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 92(6):883–887PubMedCrossRef
10.
Zurück zum Zitat Dong C, Hemminki K (2001) Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996. Int J Cancer 93(2):155–161PubMedCrossRef Dong C, Hemminki K (2001) Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996. Int J Cancer 93(2):155–161PubMedCrossRef
11.
Zurück zum Zitat Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ et al (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30(35):4330–4336PubMedCrossRef Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ et al (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30(35):4330–4336PubMedCrossRef
12.
Zurück zum Zitat Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28(14):2404–2410PubMedCrossRef Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28(14):2404–2410PubMedCrossRef
13.
Zurück zum Zitat Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887–5892PubMedCrossRef Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887–5892PubMedCrossRef
14.
Zurück zum Zitat Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335PubMedCrossRef Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335PubMedCrossRef
15.
Zurück zum Zitat Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, Malone KE, Knight JA, Capanu M, Teraoka SN et al (2013) Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 31(4):433–439PubMedCrossRef Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, Malone KE, Knight JA, Capanu M, Teraoka SN et al (2013) Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 31(4):433–439PubMedCrossRef
16.
Zurück zum Zitat Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855–861PubMed Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855–861PubMed
17.
Zurück zum Zitat Beckmann KR, Buckingham J, Craft P, Dahlstrom JE, Zhang Y, Roder D, Stuart-Harris R (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158–164PubMedCrossRef Beckmann KR, Buckingham J, Craft P, Dahlstrom JE, Zhang Y, Roder D, Stuart-Harris R (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158–164PubMedCrossRef
18.
Zurück zum Zitat Bernstein JL, Thompson WD, Risch N, Holford TR (1992) The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136(8):937–948PubMed Bernstein JL, Thompson WD, Risch N, Holford TR (1992) The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136(8):937–948PubMed
19.
Zurück zum Zitat Hemminki K, Ji J, Forsti A (2007) Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res 67(3):868–870PubMedCrossRef Hemminki K, Ji J, Forsti A (2007) Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res 67(3):868–870PubMedCrossRef
20.
Zurück zum Zitat Ji J, Hemminki K (2007) Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 105(2):229–236PubMedCrossRef Ji J, Hemminki K (2007) Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 105(2):229–236PubMedCrossRef
21.
Zurück zum Zitat McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261):624–628PubMedCrossRef McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261):624–628PubMedCrossRef
22.
Zurück zum Zitat Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos SI, Ashworth A, Peto J (2005) Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366(9496):1554–1557PubMedCrossRef Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos SI, Ashworth A, Peto J (2005) Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366(9496):1554–1557PubMedCrossRef
23.
Zurück zum Zitat Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377–382PubMedCrossRef Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377–382PubMedCrossRef
24.
Zurück zum Zitat Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A et al (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9):1384–1392PubMedCentralPubMedCrossRef Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A et al (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9):1384–1392PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Hemminki K, Mutanen P (2001) Genetic epidemiology of multistage carcinogenesis. Mutat Res 473(1):11–21PubMedCrossRef Hemminki K, Mutanen P (2001) Genetic epidemiology of multistage carcinogenesis. Mutat Res 473(1):11–21PubMedCrossRef
26.
Zurück zum Zitat Li CI, Malone KE, Weiss NS, Daling JR (2001) Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 93(13):1008–1013PubMedCrossRef Li CI, Malone KE, Weiss NS, Daling JR (2001) Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 93(13):1008–1013PubMedCrossRef
27.
Zurück zum Zitat Servant N, Bollet MA, Halfwerk H, Bleakley K, Kreike B, Jacob L, Sie D, Kerkhoven RM, Hupe P, Hadhri R et al (2012) Search for a gene expression signature of breast cancer local recurrence in young women. Clin Cancer Res 18(6):1704–1715PubMedCrossRef Servant N, Bollet MA, Halfwerk H, Bleakley K, Kreike B, Jacob L, Sie D, Kerkhoven RM, Hupe P, Hadhri R et al (2012) Search for a gene expression signature of breast cancer local recurrence in young women. Clin Cancer Res 18(6):1704–1715PubMedCrossRef
28.
Zurück zum Zitat Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886PubMedCrossRef Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886PubMedCrossRef
29.
Zurück zum Zitat Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception 54(3 Suppl):1S–106S; 1996 Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception 54(3 Suppl):1S–106S; 1996
30.
Zurück zum Zitat Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22(3):344–350PubMedCrossRef Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22(3):344–350PubMedCrossRef
31.
Zurück zum Zitat Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9(3):221–236PubMedCrossRef Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9(3):221–236PubMedCrossRef
32.
Zurück zum Zitat Leu M, Reilly M, Czene K (2008) Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. J Natl Cancer Inst 100(18):1318–1325PubMedCrossRef Leu M, Reilly M, Czene K (2008) Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. J Natl Cancer Inst 100(18):1318–1325PubMedCrossRef
33.
Zurück zum Zitat Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27–33PubMedCrossRef Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27–33PubMedCrossRef
34.
Metadaten
Titel
Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study
Publikationsdatum
01.02.2014
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2848-3

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.